Briacell Therapeutics Corp's stock has seen a slight decline this week amid ongoing developments in the healthcare sector.
Briacell Therapeutics Corp (BCT.TO) has experienced a decrease in share price this week, closing at C$5.75, down 3.61% on the day and 2.33% over the week. Despite this recent downturn, the stock has shown a positive trend over the past month, with a gain of 16.44%. Investors are paying attention to both the performance metrics and the recent company developments as they assess the stock's potential.
Advertisement
Briacell Therapeutics Corp
BCT.TO
BCT.TO
Briacell Therapeutics Corp
WealthAwesomeMarket cap
$53.07M
52W high
$20.40
52W low
$3.68
1W change
-2.33%
Beta
1.53
Analyst Price Targets
Based on analyst covering BCT · as of Sep 17, 2026
Wall Street analysts forecast BCT stock price to rise 240.1% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$20.00
+240.1% Upside
Current Price
C$5.88
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BCT's historical volatility
30-Day Vol
86.7%
Annualized
90-Day Vol
71.9%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$7.03
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$6.24 | C$4.63 – C$8.42 |
| 60 trading days | C$6.62 | C$4.34 – C$10.11 |
| 90 trading days | C$7.03 | C$4.19 – C$11.80 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Briacell Therapeutics continues to navigate a challenging market, with notable fluctuations in stock price. Investors should consider the company's recent activities and overall market sentiment in the healthcare sector when evaluating potential investment opportunities.
Briacell Therapeutics Corp's stock closed at C$5.75 this week.
The stock has a 52-week range of C$3.68 to C$20.40, indicating significant volatility over the past year.
Bull case
Analysts are optimistic about Briacell, with an average target price of C$20.00. This suggests there’s considerable upside potential from current levels. The company’s ongoing research and development efforts, especially with the Bria-OTS™ platform, could drive future growth.
Bear case
However, the stock has struggled this year, down 40.12%, and the recent price drop may raise concerns about the company's short-term viability. Additionally, the negative return on equity and lack of profit margin could deter risk-averse investors.
Recent Stock Performance
Advertisement
Briacell Therapeutics Corp's stock has seen a decline this week, closing at C$5.75. This represents a 3.61% drop on Monday and a 2.33% decrease over the past week. However, the stock has shown resilience with a 16.44% increase over the past month, indicating some recovery from earlier lows.
Company News and Developments
There were no significant news announcements from Briacell Therapeutics this week. However, the company has been active in the past months, including the completion of a share offering and presentations of preclinical data. These developments may contribute to investor sentiment as they evaluate the company's future prospects.
Technical Picture
From a technical standpoint, Briacell's stock is currently trading above its 50-day moving average of C$5.16, reflecting an 11.5% premium. However, it is slightly below its 200-day moving average of C$5.94, indicating some resistance at higher price levels. The stock has a beta of 1.53, suggesting higher volatility compared to the broader market. Recent trading volume was 4,650 shares, which is about 50% of the 20-day average volume of 9,685 shares, indicating lower trading activity.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
